Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for End-Point Testing During Drying Process – V 2.0

Posted on By

Tablets: SOP for End-Point Testing During Drying Process – V 2.0

Standard Operating Procedure for End-Point Testing During Drying Process

Department Tablet
SOP No. SOP/TAB/151/2025
Supersedes SOP/TAB/151/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for performing end-point testing during the drying process of tablet granules to ensure that they reach the desired moisture content before further processing.

2. Scope

This SOP applies to the drying process of tablet granules, specifically focusing on the testing performed to determine when the granules have reached the optimal moisture content.

3. Responsibilities

  • Quality Control (QC): Responsible for performing the end-point testing on granules to verify that the moisture content is within acceptable limits.
  • Drying Operator: Responsible for ensuring the drying process is carried out according to the prescribed parameters and for notifying QC when testing is required.
  • Quality Assurance (QA): Ensures that end-point testing procedures are followed correctly, reviews test results, and approves corrective actions if necessary.

See also  Tablets: SOP for Training Record Maintenance in QA Departments - V 2.0

4. Accountability

The QC Manager is accountable for ensuring that the end-point testing is carried out regularly during the drying process. The QA Manager reviews the test results and approves corrective actions as needed.

5. Procedure

5.1 Sampling

  1. Collect representative samples of granules from the drying bed or drying equipment at defined intervals during the drying process.
  2. Ensure that samples are taken from different points within the batch to accurately reflect the moisture content across the entire batch.

5.2 Moisture Content Testing

  1. Perform moisture content testing on the collected samples using an appropriate method, such as a moisture analyzer or oven-drying method.
  2. Ensure the test method used is validated for the specific granules being tested.
  3. Test moisture content at least twice per batch or as per established sampling plan.

5.3 End-Point Determination

  1. Compare the results of the moisture content testing to the acceptable moisture content range for the granules. This range should be predefined based on the formulation requirements.
  2. The batch is considered dried when the moisture content falls within the specified range, typically between 2-5% for most tablet formulations.
  3. If the moisture content is outside the acceptable range, the granules should be returned to the dryer for further drying, and additional testing should be conducted.
See also  Tablets: SOP for Hardness Testing of Chewable Tablets - V 2.0

5.4 Documentation

  1. Document the results of the moisture content testing in the batch record (Annexure-2), including the moisture content percentage, the sampling time, and the method used for testing.
  2. Note any deviations or corrective actions taken, such as further drying if the moisture content is too high.

5.5 Corrective Actions

  1. If the moisture content is found to be outside the acceptable limits, initiate corrective actions such as adjusting the drying time, temperature, or airflow in the drying equipment.
  2. After corrective actions are taken, perform further testing to verify that the moisture content falls within the acceptable range before proceeding with tablet compression.

5.6 Post-Testing Actions

  1. If the batch passes the end-point testing and meets the desired moisture content, proceed with further tablet manufacturing steps, such as granulation or compression.
  2. If the batch fails, perform a root cause analysis, modify the drying process, and re-test until the correct moisture content is achieved.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • Moisture Content: The amount of water present in the granules, typically expressed as a percentage of the total weight.
See also  Tablets: SOP for Granulation Process for Immediate Release Tablets - V 2.0

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <701> – Moisture Testing for Granules
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Guidelines for Moisture Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Moisture content exceeded the required range Adjusted drying parameters and re-dried the batch John Doe

Annexure-2: Batch Record

Sample Number Moisture Content Action Taken
Sample 1 3.0% Accepted

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated testing procedure Improved compliance QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Prevention of Cross-Contamination in Raw Material Storage – V 2.0
Next Post: Capsule: SOP for Conducting Line Clearance Before Starting Capsule Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version